Access cutting-edge breast cancer treatment through this clinical trial at a research site in Durham. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Durham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
The purpose of this study is to test the safety and effectiveness of the study drug datopotamab deruxtecan in participants with metastatic breast cancer that has spread to the brain. The name of the study drug used in this research study is: Datopotamab deruxtecan (a type of antibody-drug conjugate)
Sponsor: Sarah Sammons, MD
Check if you qualify for this breast cancer clinical trial in Durham, NC
If you're searching for breast cancer treatment options in Durham, NC, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Durham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.